Actively Recruiting
CORONA in the Saarland
Led by Universität des Saarlandes · Updated on 2025-05-25
300
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
The CORSAAR study is an observational and prospective research project aimed at understanding the natural biology of COVID-19. It includes patients with all forms of COVID-19, including those experiencing long COVID. The study is conducted by Universität des Saarlandes and seeks to collect detailed information about the disease over time. Participants have their medical history recorded and undergo measurements and biomarker collection at the start of the study, during hospitalization if applicable, and after discharge. The study also measures serum concentrations of multiple cytokines to explore their role. Patients with long COVID are also included to understand this condition further. Throughout participation, patients are followed up and monitored to gather data on their health status, including correlations of biomarkers with mortality and disease subgroups, reviewed two years after the initial illness. The total duration and details of follow-up assessments vary by participant, focusing on understanding disease progression and long-term outcomes.
CONDITIONS
Brief Title
CORONA in the Saarland
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of any form of COVID-19, including long COVID
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Baseline and during hospitalization
Participants undergo cytokine measurements and other biomarker assessments related to COVID-19.
1 baseline visit and additional visits during hospitalization
Duration - Up to 2 years after initial disease
Participants are followed up after discharge to collect medical history, measurements, and biomarkers related to COVID-19 and long COVID.
Periodic follow-up visits after discharge
Trial Site Locations
Total: 1 location
1
Saarland University
Homburg, Saarland, Germany, 66421
Actively Recruiting
Research Team
R
Robert Bals, MD PhD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here